Concepedia

Ernie Riffer

ER

Statistics

Publications

15

Citations

1.4K

H-Index

15

Active since

1987

Affiliations

Radiant Research (United States)(Current)

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Foothill Family Clinic

GlaxoSmithKline (Belgium)

Edmonds Community College

Ernie Riffer is an author at Radiant Research (United States) specializing in pharmacotherapy, pharmacology, and pharmacy.

Publications per year

1987–2022

15

Publications

15

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Thomas R. Pieber, Bruce W. Bode, Young Min Cho et al. · The Lancet Diabetes & Endocrinology · 2019 · 274 citations · Full text

, , +9

Lasmiditan is an effective acute treatment for migraine

Bernice Kuca, Stephen D. Silberstein, Linda Wietecha et al. · Neurology · 2018 · 267 citations · Full text

, , +14

Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults

Sam Jackson, Joseph R. Lentino, James Kopp et al. · Vaccine · 2017 · 192 citations · Full text

, , +15

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Ana Strezova, Javier Díez‐Domingo, Kamal Al Shawafi et al. · Open Forum Infectious Diseases · 2022 · 101 citations · Full text

, , +17

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Yajing Bao, Joy Beeler, Weerawat Manosuthi et al. · The Lancet Infectious Diseases · 2017 · 99 citations · Full text

, , +10

1–5 of 15